Skip to content

REGENOCELL THERAPEUTICS, INC.

CIK 0001221749

← back to feed
Revenue (TTM)
$803.58K
−4.9% YoY FY Mar 2012
Net Income (TTM)
−$1.45M
+66.0% YoY FY Mar 2012
EPS Diluted (TTM)
—
FY Mar 2012
Gross Margin
84.2%
FY Mar 2012
Operating Margin
-116.2%
FY Mar 2012
Net Margin
-180.9%
FY Mar 2012
Free Cash Flow (TTM)
—
FY Mar 2012
Cash
$11.05K
FY Mar 2012
Total Debt
—
FY Mar 2012
Shares Outstanding
90.43M sh
FY Mar 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings